List view / Grid view

Hervé Hoppenot

 

news

Novartis receives EU approval for Votubia®

The European Commission has approved Votubia® (everolimus) tablets* for the…

8 September 2011 | By Novartis

The European Commission has approved Votubia® (everolimus) tablets* for the treatment of patients aged 3 years and older...

news

Novartis gains FDA approval for Afinitor®

Novartis announced today that the FDA approved Afinitor® (everolimus) tablets…

5 May 2011 | By Novartis

Novartis announced today that the FDA approved Afinitor® (everolimus) tablets for the treatment of progressive neuroendocrine tumors of pancreatic origin (PNET)...